Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design

The absorption of poorly water-soluble drugs is influenced by the luminal gastrointestinal fluid content and composition, which control solubility. Simulated intestinal fluids have been introduced into dissolution testing including endogenous amphiphiles and digested lipids at physiological levels; however, in vivo individual variation exists in the concentrations of these components, which will alter drug absorption through an effect on solubility. The use of a factorial design of experiment and varying media by introducing different levels of bile, lecithin, and digested lipids has been previously reported, but here we investigate the solubility variation of poorly soluble drugs through more complex biorelevant amphiphile interactions. A four-component mixture design was conducted to understand the solubilization capacity and interactions of bile salt, lecithin, oleate, and monoglyceride with a constant total concentration (11.7 mM) but varying molar ratios. The equilibrium solubility of seven low solubility acidic (zafirlukast), basic (aprepitant, carvedilol), and neutral (fenofibrate, felodipine, griseofulvin, and spironolactone) drugs was investigated. Solubility results are comparable with literature values and also our own previously published design of experiment studies. Results indicate that solubilization is not a sum accumulation of individual amphiphile concentrations, but a drug specific effect through interactions of mixed amphiphile compositions with the drug. This is probably due to a combined interaction of drug characteristics; for example, lipophilicity, molecular shape, and ionization with amphiphile components, which can generate specific drug–micelle affinities. The proportion of each component can have a remarkable influence on solubility with, in some cases, the highest and lowest points close to each other. A single-point solubility measurement in a fixed composition simulated media or human intestinal fluid sample will therefore provide a value without knowledge of the surrounding solubility topography meaning that variability may be overlooked. This study has demonstrated how the amphiphile ratios influence drug solubility and highlights the importance of the envelope of physiological variation when simulating in vivo drug behavior.

[1]  T. Loftsson,et al.  Carvedilol: Solubilization and Cyclodextrin Complexation: A Technical Note , 2008, AAPS PharmSciTech.

[2]  A. Berthod,et al.  Hydrophobicity of Ionizable Compounds. A Theoretical Study and Measurements of Diuretic Octanol−Water Partition Coefficients by Countercurrent Chromatography , 1999 .

[3]  Anette Müllertz,et al.  A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids , 2000, Pharmaceutical Research.

[4]  Ben J Boyd,et al.  Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. , 2004, Journal of pharmaceutical sciences.

[5]  J. Tack,et al.  Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Hans Lennernäs,et al.  The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.

[7]  V. David,et al.  Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples. , 2010, Journal of pharmaceutical and biomedical analysis.

[8]  J. Tack,et al.  Drug supersaturation in simulated and human intestinal fluids representing different nutritional states. , 2010, Journal of pharmaceutical sciences.

[9]  J. Dressman,et al.  Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration , 2004, Pharmaceutical Research.

[10]  Frederick A. Heberle,et al.  Phase diagram of a 4-component lipid mixture: DSPC/DOPC/POPC/chol. , 2013, Biochimica et biophysica acta.

[11]  T. Rades,et al.  Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  P Augustijns,et al.  Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. , 2009, Journal of pharmaceutical sciences.

[13]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[14]  David K. Chalmers,et al.  Glyceride Lipid Formulations: Molecular Dynamics Modeling of Phase Behavior During Dispersion and Molecular Interactions Between Drugs and Excipients , 2013, Pharmaceutical Research.

[15]  Raimund Mannhold,et al.  The impact of lipophilicity in drug research: a case report on beta-blockers. , 2005, Mini reviews in medicinal chemistry.

[16]  B. Mishra,et al.  Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH. , 2009, Journal of colloid and interface science.

[17]  D. Cistola,et al.  The Ionization Behavior of Fatty Acids and Bile Acids in Micelles and Membranes , 1984, Hepatology.

[18]  J. Dressman,et al.  Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  A. Müllertz,et al.  Structural features of colloidal species in the human fasted upper small intestine , 2015, The Journal of pharmacy and pharmacology.

[20]  Eva Karlsson,et al.  Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids. , 2010, Molecular pharmaceutics.

[21]  Mark McAllister,et al.  Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  J. Dressman,et al.  Influence of Hydrodynamics and Particle Size on the Absorption of Felodipine in Labradors , 2004, Pharmaceutical Research.

[23]  A. Müllertz,et al.  Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies , 2010, The Journal of pharmacy and pharmacology.

[24]  Anette Müllertz,et al.  In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  G. Duchateau,et al.  Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs , 2009, Pharmaceutical Research.

[26]  H. Kristensen,et al.  Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol. , 2006, Journal of pharmaceutical sciences.

[27]  J. Dressman,et al.  Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data. , 2014, Journal of pharmaceutical sciences.

[28]  Johan Ulander,et al.  Computational Prediction of Drug Solubility in Fasted Simulated and Aspirated Human Intestinal Fluid , 2014, Pharmaceutical Research.

[29]  P. Baatsen,et al.  An In-Depth View into Human Intestinal Fluid Colloids: Intersubject Variability in Relation to Composition. , 2016, Molecular pharmaceutics.

[30]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[31]  K. Edwards,et al.  Aggregate structure in dilute aqueous dispersions of oleic acid/sodium oleate and oleic acid/sodium oleate/egg phosphatidylcholine , 1995 .

[32]  A. Hofmann The behavior and solubility of monoglycerides in dilute, micellar bile-salt solution. , 1963, Biochimica et biophysica acta.

[33]  Clive G. Wilson,et al.  Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  Bart Hens,et al.  A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  J. Dressman,et al.  An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine , 2012, Pharmaceutical Research.

[36]  J. Dressman,et al.  Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update , 2008, Pharmaceutical Research.

[37]  Clive G. Wilson,et al.  Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[38]  H. Kristensen,et al.  A dynamic in vitro lipolysis model. II: Evaluation of the model. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  Christos Reppas,et al.  Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects , 2004, The Journal of pharmacy and pharmacology.

[40]  A. Müllertz,et al.  Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity. , 2010, Journal of pharmaceutical sciences.

[41]  B. Boyd,et al.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. , 2003, Journal of pharmaceutical sciences.

[42]  G. Duchateau,et al.  Pharmaceutics, Drug Delivery and Pharmaceutical Technology Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions , 2016 .

[43]  Raviraj Pillai,et al.  Inclusion complex of aprepitant with cyclodextrin: evaluation of physico-chemical and pharmacokinetic properties , 2013, Drug development and industrial pharmacy.

[44]  R. G. Crounse Effective use of griseofulvin. , 1963, Archives of dermatology.

[45]  B. Müller,et al.  Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  K. Goumas,et al.  Precipitation in and Supersaturation of Contents of the Upper Small Intestine After Administration of Two Weak Bases to Fasted Adults , 2011, Pharmaceutical Research.